External Projects:
Service Projects (SPs)


SPs should exploit more mature capabilities, technologies, and devices developed at the Center. 

 SPs are expected to be externally funded prior to beginning work.


Existing Service Projects

Locations of Service Project institutions. Red pins: new or continuing projects. Numbers correspond to table on left. Yellow pins: CCMEEC completed projects
  • PI & Institution: Robby Bowles, The University of Utah, Salt Lake City, UT
  • Title: Identification of new target that will drive osteogenesis
  • Funding Source: U. of Utah Start-up Funds and NIH
  • PI & Institution:Tomas Kean, Biionix Cluster, College of Medicine, U. of Central Florida, Orlando, FL
  • Title: Use and validation of chondrocyte cell reporters for cartilage tissue engineering leading to improved in vitro culture and drug discovery
  • Funding Source: Biionix startup funds
  • PI & Institution: Anand R. Kumar, University Hospitals Cleveland, OH
  • Title: Muscle Derived Stem Cells for Healing Volumetric Muscle Loss
  • Funding Source: PSF/MTF Biologics Allograft Tissue Research
  • PI & Institution: Aijun Wang, UC Davis School of Medicine, Davis, CA
  • Title: Manufacturing GMP grade placental MSCs for clinical applications
  • Funding Source: NIH
  • PI & Institution: Alexander Revzin, Mayo Clinic, Rochester, MN
  • Title:Bioreactor process standardization during pancreatic islet differentiation culture
  • Funding Source: NIH
  • Philadelphia, PA  
  • Actuator interface for compression shear-stimuli bioreactor    
  • Children’s Hospital of Philadelphia (CHOP) startup Funds
  • PI & Institution: Jeffrey Millman, Ph.D., Washington University School of Medicine, St. Louis, MO
  • Title: Determining the mechanism of IFIH1 disease-associated variants on beta-cell and immune responses in Type 1 diabetes
  • Funding Source: NIH R01DK127497
  • PI & Institution: Emilio Barbera-Guillem, MD, Ph.D., Celartia® Ltd, Columbus, OH
  • Title: Oxygen monitoring in CAR-T cell therapy production system.
  • Funding Source: Celartia® corporate funds. NIH: 75N91021C00016-0-9999-1
  • PI & Institution:Fernando Albornoz, Inbiocriotec S.A. Valparaiso, Chile
  • Title: Preservation and transport of engineered tissues
  • Funding Source: Inbiocriotec corporate funds
  • PI & Institution: Agustin Martinez, Ph.D.,  Interdisciplinary Center of Neurosciences, Faculty of Science, Valparaiso University, Valparaiso, Chile
  • Co-PI: Caroline Weinstein, Ph.D., Faculty of Pharmacy, Valparaiso University.
  • Title: Development and optimization of a scaffold for the treatment of Venous ulcers
  • Funding Source: ID21I10153, Fondef, Chile
  • PI & Institution: Maneesh Dave, UC Davis
  • Title:Davis, Davis, CA Homing of mesenchymal cells to experimental mouse model of bowel diseases
  • Funding Source: NIH
  • PI & Institution: Aldo R. Boccaccini, Ph.D., University of Erlangen-Nuremberg, Institute of Biomaterials, Erlangen, Germany.
  • Title: Use and validation of sensor/reporters for bone tissue engineering using novel biomaterials and scaffold manufacturing processes.
  • Funding Source:Institute of Biomaterials internal funds
  • PI & Institution: Franco Kraiselburd Asclepii, Inc, Cleveland, OH
  • Title: Generation of a therapeutic platform for wound healing
  • Funding Source: CNV-24082023-18
  • PI & Institution: Julie Renner, Ph.D. Case Western Reserve University
  • Title: Peptide Engineering to Control Cell Phenotype and Differentiation
  • Funding Source: JMKEF7EJW69
Interested in initiating a new service project?

Regulatory

Membership

ARMI

The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization whose mission is to advance the bioeconomy of the United States. The institute’s work will positively impact not only manufacturing but also healthcare and education and workforce development in the country.

Commercialization

The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization whose mission is to advance the bioeconomy of the United States. The institute’s work will positively impact not only manufacturing but also healthcare and education and workforce development in the country.